A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Condition: Ulcerative ColitisInterventions: Drug: LT-02; Drug: LT-02 PlaceboSponsors: Prometheus Laboratories; Nestlè Health Science; INC ResearchRecruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2016 Category: Research Source Type: clinical trials
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Condition: Ulcerative Colitis Interventions: Drug: LT-02; Drug: LT-02 Placebo Sponsors: Prometheus Laboratories; Nestlè Health Science; INC Research Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2016 Category: Research Source Type: clinical trials
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Condition: Ulcerative Colitis Interventions: Drug: LT-02; Drug: LT-02 Placebo Sponsors: Prometheus Laboratories; Nestlè Health Science; INC Research Recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2016 Category: Research Source Type: clinical trials
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Condition: Ulcerative Colitis Interventions: Drug: LT-02; Drug: LT-02 Placebo Sponsors: Prometheus Laboratories; Nestlé Health Science Spain; INC Research Recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2016 Category: Research Source Type: clinical trials
Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
Condition: Ulcerative ColitisInterventions: Drug: Mesalamine; Drug: PlaceboSponsor: Ferring PharmaceuticalsNot yet recruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2015 Category: Research Source Type: clinical trials
Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)
Condition: Ulcerative ColitisInterventions: Drug: Mesalamine; Drug: PlaceboSponsor: Ferring PharmaceuticalsNot yet recruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2015 Category: Research Source Type: clinical trials
Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
Condition: Ulcerative ColitisInterventions: Drug: Mesalamine; Drug: PlaceboSponsor: Ferring PharmaceuticalsNot yet recruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2015 Category: Research Source Type: clinical trials
Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)
Condition: Ulcerative ColitisInterventions: Drug: Mesalamine; Drug: PlaceboSponsor: Ferring PharmaceuticalsNot yet recruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2015 Category: Research Source Type: clinical trials
Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
Condition: Ulcerative ColitisInterventions: Drug: Mesalamine; Drug: PlaceboSponsor: Ferring PharmaceuticalsNot yet recruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2015 Category: Research Source Type: clinical trials
Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)
Condition: Ulcerative ColitisInterventions: Drug: Mesalamine; Drug: PlaceboSponsor: Ferring PharmaceuticalsNot yet recruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2015 Category: Research Source Type: clinical trials
